- Home
- TIRX vs LGVN Comparison
TIRX vs LGVN Comparison
Compare TIRX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIRX | LGVN |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 11.9M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TIRX | LGVN |
|---|---|---|
| Price | $0.03 | $0.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 42.1M | 437.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $709,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.02 | $0.49 |
| 52 Week High | $3.45 | $1.92 |
Technical Indicators
Market Signals| Indicator | TIRX | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.41 | 44.24 |
| Support Level | N/A | $0.50 |
| Resistance Level | $0.12 | $0.68 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 5.85 | 15.60 |
Price Performance
Historical ComparisonAbout TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.